{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:11:00Z","timestamp":1787847060958,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs\u201d commissioned by the Chinese Association of Research Hospitals","award":["No. Y2024FH-YWPJ02"],"award-info":[{"award-number":["No. Y2024FH-YWPJ02"]}]},{"name":"the Key Project of Medical Innovation Project in 2017","award":["No. 17CXZ010"],"award-info":[{"award-number":["No. 17CXZ010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11096-025-01984-2","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T09:47:28Z","timestamp":1755596848000},"page":"1841-1851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical prediction of sodium valproate-induced movement disorders in hospitalized patients: a nomogram-based model using real-world data"],"prefix":"10.1007","volume":"47","author":[{"given":"Liqiang","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daihong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"9","key":"1984_CR1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1474-4422(19)30152-8","volume":"18","author":"SA Factor","year":"2019","unstructured":"Factor SA, Burkhard PR, Caroff S, et al. Recent developments in drug-induced movement disorders: a mixed picture. Lancet Neurol. 2019;18(9):880\u201390. https:\/\/doi.org\/10.1016\/S1474-4422(19)30152-8.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1984_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-0043-1763510","volume":"43","author":"S Pandey","year":"2023","unstructured":"Pandey S, Pitakpatapee Y, Saengphatrachai W, et al. Drug-induced movement disorders. Semin Neurol. 2023;43(1):35\u201347. https:\/\/doi.org\/10.1055\/s-0043-1763510.","journal-title":"Semin Neurol."},{"key":"1984_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5334\/tohm.587","volume":"10","author":"A Chouksey","year":"2020","unstructured":"Chouksey A, Pandey S. Clinical spectrum of drug-induced movement disorders: a study of 97 patients. Tremor Other Hyperkinet Mov (NY). 2020;10:48. https:\/\/doi.org\/10.5334\/tohm.587.","journal-title":"Tremor Other Hyperkinet Mov. (N.Y)"},{"key":"1984_CR4","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.2147\/NDT.S261272","volume":"16","author":"T Misgana","year":"2020","unstructured":"Misgana T, Yigzaw N, Asfaw G. Drug-induced movement disorders and its associated factors among patients attending treatment at public hospitals in Eastern Ethiopia. Neuropsychiatr Dis Treat. 2020;16:1987\u201395. https:\/\/doi.org\/10.2147\/NDT.S261272.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1984_CR5","doi-asserted-by":"publisher","first-page":"120192","DOI":"10.1016\/j.jns.2022.120192","volume":"435","author":"JF Baizabal-Carvallo","year":"2022","unstructured":"Baizabal-Carvallo JF, Morgan JC. Drug-induced tremor, clinical features, diagnostic approach and management. J Neurol Sci. 2022;435:120192. https:\/\/doi.org\/10.1016\/j.jns.2022.120192.","journal-title":"J Neurol Sci."},{"key":"1984_CR6","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.695","volume":"12","author":"GT Kannarkat","year":"2022","unstructured":"Kannarkat GT, Caroff SN, Morley JF. Risk of drug-induced movement disorders with newer antipsychotic agents. Tremor Other Hyperkinet Mov (N Y). 2022;12: 19. https:\/\/doi.org\/10.5334\/tohm.695.","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"Pt A","key":"1984_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.108693","volume":"131","author":"DJ Zhou","year":"2022","unstructured":"Zhou DJ, Pavuluri S, Snehal I, et al. Movement disorders associated with antiseizure medications: a systematic review. Epilepsy Behav. 2022;131(Pt A): 108693. https:\/\/doi.org\/10.1016\/j.yebeh.2022.108693.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"1984_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.14712\/23362936.2021.14","volume":"122","author":"JP Rissardo","year":"2021","unstructured":"Rissardo JP, Caprara ALF, Durante \u00cd. Valproate-associated movement disorder: a literature review. Prague Med Rep. 2021;122(3):140\u201380. https:\/\/doi.org\/10.14712\/23362936.2021.14.","journal-title":"Prague Med Rep"},{"issue":"6197","key":"1984_CR9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/bmj.2.6197.1035-a","volume":"2","author":"A Lautin","year":"1979","unstructured":"Lautin A, Stanley M, Angrist B, et al. Extrapyramidal syndrome with sodium valproate. Br Med J. 1979;2(6197):1035\u20136. https:\/\/doi.org\/10.1136\/bmj.2.6197.1035-a.","journal-title":"Br Med J"},{"issue":"2","key":"1984_CR10","first-page":"37","volume":"13","author":"P Nasr Esfahani","year":"2019","unstructured":"Nasr Esfahani P, Nasiri J, Badihian S, et al. Short-term side efects of low dose valproate monotherapy in epileptic children: a prospective study. Iran J Child Neurol. 2019;13(2):37\u201346.","journal-title":"Iran J Child Neurol"},{"key":"1984_CR11","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.755","volume":"13","author":"K Sekiguchi","year":"2023","unstructured":"Sekiguchi K, Mashiko T, Koide R, et al. A case of long-term exposure to Valproic acid mimicking tremor-dominant Parkinson\u2019s disease. Tremor Other Hyperkinet Mov (N Y). 2023;13: 17. https:\/\/doi.org\/10.5334\/tohm.755.","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"11","key":"1984_CR12","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1111\/bcp.14853","volume":"87","author":"A Madan","year":"2021","unstructured":"Madan A, Donovan PJ, Risetto T, et al. Monitoring for valproate and phenytoin toxicity in hypoalbuminaemia: a retrospective cohort study. Br J Clin Pharmacol. 2021;87(11):4341\u201353. https:\/\/doi.org\/10.1111\/bcp.14853.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1984_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","volume":"40","author":"PN Patsalos","year":"2018","unstructured":"Patsalos PN, Spencer EP, Berry DJ. Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update. Ther Drug Monit. 2018;40(5):526\u201348. https:\/\/doi.org\/10.1097\/FTD.0000000000000546.","journal-title":"Ther Drug Monit"},{"key":"1984_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.890221","volume":"13","author":"P Zheng","year":"2022","unstructured":"Zheng P, Yu Z, Mo L, et al. An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques. Front Pharmacol. 2022;13: 890221. https:\/\/doi.org\/10.3389\/fphar.2022.890221.","journal-title":"Front Pharmacol"},{"key":"1984_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jad.2023.11.047","volume":"347","author":"CW Hsu","year":"2024","unstructured":"Hsu CW, Lai EC, Chen YB, et al. Valproic acid monitoring: serum prediction using a machine learning framework from multicenter real-world data. J Affect Disord. 2024;347:85\u201391. https:\/\/doi.org\/10.1016\/j.jad.2023.11.047.","journal-title":"J Affect Disord"},{"issue":"2","key":"1984_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3969\/j.issn.1008-9926.2023.02.001","volume":"36","author":"DH Guo","year":"2023","unstructured":"Guo DH, Zhu M, Xu YJ, et al. Establishment and implementation of informatized pharmacovigilance systems in the military. Pharm J Chin PLA. 2023;36(2):95\u20139. https:\/\/doi.org\/10.3969\/j.issn.1008-9926.2023.02.001.","journal-title":"Pharm J Chin PLA"},{"issue":"2","key":"1984_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345. https:\/\/doi.org\/10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1984_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266267","volume":"18","author":"A Daneshvar","year":"2023","unstructured":"Daneshvar A, Mousa G. Regression shrinkage and selection via least quantile shrinkage and selection operator. PLoS One. 2023;18(2): e0266267. https:\/\/doi.org\/10.1371\/journal.pone.0266267.","journal-title":"PLoS One"},{"issue":"1","key":"1984_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07916-3","volume":"21","author":"D Zhou","year":"2021","unstructured":"Zhou D, Liu X, Wang X, et al. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC Cancer. 2021;21(1): 246. https:\/\/doi.org\/10.1186\/s12885-021-07916-3.","journal-title":"BMC Cancer"},{"issue":"6","key":"1984_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40263-016-0341-8","volume":"30","author":"F Brugger","year":"2016","unstructured":"Brugger F, Bhatia KP, Besag FM. Valproate-associated parkinsonism: a critical review of the literature. CNS Drugs. 2016;30(6):527\u201340. https:\/\/doi.org\/10.1007\/s40263-016-0341-8.","journal-title":"CNS Drugs"},{"issue":"11","key":"1984_CR21","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1111\/bcp.15836","volume":"89","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wei Z, Chen S, et al. Movement disorders associated with antiseizure medications: a real-world disproportionality analysis of the food and drug administration adverse event reporting system. Br J Clin Pharmacol. 2023;89(11):3389\u2013400. https:\/\/doi.org\/10.1111\/bcp.15836.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1984_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.19577\/j.1007-4406.2022.02.001","volume":"31","author":"XM Feng","year":"2022","unstructured":"Feng XM, He N, Zhai SD. Data mining and analysis of adverse reaction signals of sodium valproate and levetiracetam in children based on FDA adverse event reporting system. Chin J Clin Pharm. 2022;31(2):81\u20137. https:\/\/doi.org\/10.19577\/j.1007-4406.2022.02.001.","journal-title":"Chin J Clin Pharm"},{"issue":"8","key":"1984_CR23","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40263-022-00937-x","volume":"36","author":"M S\u00e1enz-Farret","year":"2022","unstructured":"S\u00e1enz-Farret M, Tijssen MAJ, Eliashiv D, et al. Antiseizure drugs and movement disorders. CNS Drugs. 2022;36(8):859\u201376. https:\/\/doi.org\/10.1007\/s40263-022-00937-x.","journal-title":"CNS Drugs"},{"issue":"25","key":"1984_CR24","doi-asserted-by":"publisher","first-page":"22424","DOI":"10.1074\/jbc.M301789200","volume":"278","author":"S Dasgupta","year":"2003","unstructured":"Dasgupta S, Jana M, Liu X, et al. Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflammatory cytokines in microglial cells. J Biol Chem. 2003;278(25):22424\u201331. https:\/\/doi.org\/10.1074\/jbc.M301789200.","journal-title":"J Biol Chem"},{"issue":"12","key":"1984_CR25","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/jnnp-2022-330394","volume":"94","author":"R Kim","year":"2023","unstructured":"Kim R, Kang N, Byun K, et al. Prognostic significance of peripheral neutrophils and lymphocytes in early untreated Parkinson\u2019s disease: an 8-year follow-up study. J Neurol Neurosurg Psychiatry. 2023;94(12):1040\u20136. https:\/\/doi.org\/10.1136\/jnnp-2022-330394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1984_CR26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s11096-025-01919-x","volume":"47","author":"I Fitzgerald","year":"2025","unstructured":"Fitzgerald I, Bayraktar I, Eiden B, et al. Comparative efficacy and safety of alternatives to sodium valproate in the management of bipolar affective disorder in people of child-bearing age: a narrative review by the European Society of Clinical Pharmacy\u2019s mental health specialist interest group. Int J Clin Pharm. 2025;47(3):666\u201375. https:\/\/doi.org\/10.1007\/s11096-025-01919-x.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"1984_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s11096-018-0641-9","volume":"40","author":"MSA Campos","year":"2018","unstructured":"Campos MSA, Ayres LR, Morelo MRS, et al. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses. Int J Clin Pharm. 2018;40(3):589\u201398. https:\/\/doi.org\/10.1007\/s11096-018-0641-9.","journal-title":"Int J Clin Pharm"},{"issue":"26","key":"1984_CR28","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.3969\/j.issn.1007-9572.2017.26.011","volume":"20","author":"S Jiang","year":"2017","unstructured":"Jiang S, Gao H, Li PS, et al. A meta-analysis of the correlation between lymphocyte subsets and Parkinson\u2019s disease. Chin Gen Pract. 2017;20(26):3251\u20138. https:\/\/doi.org\/10.3969\/j.issn.1007-9572.2017.26.011.","journal-title":"Chin Gen Pract"},{"key":"1984_CR29","doi-asserted-by":"publisher","unstructured":"Marson A, Burnside G, Appleton R, et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021;397(10282):1375\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(21)00246-4. Erratum in: Lancet. 2021 Apr 24;397(10284):1544.. Erratum in: Lancet. 2021 May 15;397(10287):1808.","DOI":"10.1016\/S0140-6736(21)00246-4"},{"issue":"6","key":"1984_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.16780\/j.cnki.sjssgncj.20230364","volume":"18","author":"X Liu","year":"2023","unstructured":"Liu X, Cai HH, Zheng YC. Alpha-Synuclein species in red blood cells as biomarkers for early-onset Parkinson\u2019s disease. Neural Inj Funct Reconstr. 2023;18(6):311\u20135. https:\/\/doi.org\/10.16780\/j.cnki.sjssgncj.20230364.","journal-title":"Neural Inj Funct Reconstr"},{"issue":"1","key":"1984_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jns.2005.07.006","volume":"239","author":"Z Hartai","year":"2005","unstructured":"Hartai Z, Klivenyi P, Janaky T, et al. Kynurenine metabolism in plasma and in red blood cells in Parkinson\u2019s disease. J Neurol Sci. 2005;239(1):31\u20135. https:\/\/doi.org\/10.1016\/j.jns.2005.07.006.","journal-title":"J Neurol Sci"},{"key":"1984_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-218722","volume":"2017","author":"R Pal","year":"2017","unstructured":"Pal R, Das L, Dutta P, et al. Secondary Parkinsonism in a patient of psychogenic polydipsia. BMJ Case Rep. 2017;2017: bcr2016218722. https:\/\/doi.org\/10.1136\/bcr-2016-218722.","journal-title":"BMJ Case Rep"},{"issue":"7","key":"1984_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235365","volume":"15","author":"A Kumsa","year":"2020","unstructured":"Kumsa A, Agenagnew L, Alemu B, et al. Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma medical center, psychiatry clinic. PLoS One. 2020;15(7): e0235365. https:\/\/doi.org\/10.1371\/journal.pone.0235365.","journal-title":"PLoS One"},{"issue":"21","key":"1984_CR34","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3761\/j.issn.0254-1769.2022.21.003","volume":"57","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Zhang K, Li X, et al. Investigation and analysis of influencing factors related to dysmobility syndrome in maintenance hemodialysis patients. Chin J Nurs. 2022;57(21):2578\u201384. https:\/\/doi.org\/10.3761\/j.issn.0254-1769.2022.21.003.","journal-title":"Chin J Nurs."},{"issue":"1","key":"1984_CR35","doi-asserted-by":"publisher","first-page":"e100026","DOI":"10.1136\/gpsych-2018-100026","volume":"32","author":"J Weng","year":"2019","unstructured":"Weng J, Zhang Y, Li H, et al. Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia. Gen Psychiatr. 2019;32(1):e100026. https:\/\/doi.org\/10.1136\/gpsych-2018-100026.","journal-title":"Gen Psychiatr."},{"issue":"3","key":"1984_CR36","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s11096-025-01883-6","volume":"47","author":"P Techa-Angkoon","year":"2025","unstructured":"Techa-Angkoon P, Pitakpatapee Y, Saengphatrachai W, et al. Impact of pharmacist-physician collaboration on patient outcomes in Parkinson\u2019s disease: a randomised controlled trial in tertiary care. Int J Clin Pharm. 2025;47(3):834\u201343. https:\/\/doi.org\/10.1007\/s11096-025-01883-6.","journal-title":"Int J Clin Pharm"},{"key":"1984_CR37","doi-asserted-by":"publisher","first-page":"576579","DOI":"10.3389\/fneur.2020.576579","volume":"11","author":"CQ Zhang","year":"2020","unstructured":"Zhang CQ, He BM, Hu ML, et al. Risk of valproic acid-related tremor: a systematic review and meta-analysis. Front Neurol. 2020;11:576579. https:\/\/doi.org\/10.3389\/fneur.2020.576579.","journal-title":"Front Neurol."},{"issue":"2","key":"1984_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s13760-019-01239-8","volume":"121","author":"JF Baizabal-Carvallo","year":"2021","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M. Valproate-induced rest tremor and parkinsonism. Acta Neurol Belg. 2021;121(2):515\u20139. https:\/\/doi.org\/10.1007\/s13760-019-01239-8.","journal-title":"Acta Neurol Belg"},{"issue":"10","key":"1984_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/jnnp-2020-323646","volume":"91","author":"BM Jacobs","year":"2020","unstructured":"Jacobs BM, Belete D, Bestwick J, et al. Parkinson\u2019s disease determinants, prediction and gene-environment interactions in the UK Biobank. J Neurol Neurosurg Psychiatry. 2020;91(10):1046\u201354. https:\/\/doi.org\/10.1136\/jnnp-2020-323646.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"1984_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000519333","volume":"107","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Guo D, Kong X, et al. A risk-prediction nomogram for neutropenia or febrile neutropenia after etoposide-based chemotherapy in cancer patients: a retrospective cohort study. Pharmacology. 2022;107(1\u20132):69\u201380. https:\/\/doi.org\/10.1159\/000519333.","journal-title":"Pharmacology"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-01984-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:08:13Z","timestamp":1763554093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-01984-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-01984-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed and approved by the Ethics Committee of the Chinese People\u2019s Liberation Army General Hospital in Beijing, China (approval no. S2018-054-01, approval date May 31, 2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}